abstract |
The present invention relates to novel substituted oxindole derivatives of the formula (l) (see formula I) in which X1, X2, X3, X4, A, R1, R2, R3, R4, R5, R6, R7, R8,R9, a, m, and n are as defined in the specification. The present invention also relates to pharmaceutical agents containing said derivatives, and the use thereof for the treatment of vasopressin-dependent illnesses. |